Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy

Journal of Neuro-Oncology

Volumn 85, Issue 2, 2007, Pages 213-215

  Ruggiero, Antonio ^a   Buonuomo, Paola Sabrina ^b   Maurizi, Palma ^a   Cefalo, Maria Pia ^a   Corsello, Mirta ^a   Riccardi, Riccardo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Anticonvulsant therapy; Cranial irradiation; Erythema multiforme major; Stevens Johnson syndrome

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; PHENOBARBITAL;

ARTICLE; BRAIN SURGERY; CASE REPORT; CHILD; CONJUNCTIVITIS; DRUG WITHDRAWAL; FACE EDEMA; FEMALE; HUMAN; MACULOPAPULAR RASH; MEDULLOBLASTOMA; SEIZURE; SKIN MANIFESTATION; SKULL IRRADIATION; STEVENS JOHNSON SYNDROME; SYSTEMIC THERAPY; TOXIC EPIDERMAL NECROLYSIS;

ANTICONVULSANTS; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PHENOBARBITAL; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME;

EID: 35448978712     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9399-y     Document Type: Article

References (15)

1. Forsyth PA, Weaver S, Fulton D, Brasher PMA, Sutherland G et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30(2):106-112
2. Sirven J, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: A meta-analysis. Mayo Clin Proc 79(12):1489-1494
3. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY et al (2000) Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54(10):1886-1893
4. Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S et al (1995) An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 48(9):1099-1108
5. Rzany B, Correia O, Kelly J, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study. Lancet 353(9171):2190-2194
6. Oner Dincbas F, Yoruk S, Demirkesen C, Uzel O, Koca S (2004) Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment. Onkologie 27(4):389-392
7. Gomez-Criado MS, Ayani I, Leon-Colombo T, Ramos ML, Reneses MJ (2004) Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk. Rev Neurol 38(11):1056-1060
8. Eralp Y, Aydiner A, Tas F, Saip P, Topuz E (2001) Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation. Am J Clin Oncol 24(4):347-350
9. Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A et al (2004) Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: A risk to consider. J Neurooncol 66(3):345-350
10. Dincbas FO, Yörük S, Demirkesen C, Uzel O, Koca S (2004) Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment. Onkologie 27:389-392
11. Aydin F, Cokluk C, Senturk N, Aydin K, Canturk MT, Turanli AY (2006) Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin. J Eur Acad Dermatol Venereol 20:588
12. Khafaga YM, Jamshed A, Allam AA, Mourad WA, Ezzat A, Al Eisa A, Gray AJ, Schultz H (1999) Related articles, links Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol 38(1):111-116
13. Bastuji-Garin S, Rzany B, Stern RS et al (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96
14. Ahmed I, Reichenberg J, Lucas A, Shehan JM (2004) Erythema multiforme associated with phenytoin and cranial radiation therapy: A report of three patients and review of the literature. Int J Dermatol 43(1):67-73
15. Wohrl S, Loewe R, Pickl WF, Stingl G, Wagner SN (2005) EMPACT syndrome. J Dtsch Dermatol Ges 3(1):39-43